Middlebrook Pharmaceuticals (MBRK) 8-K Regulation FD Disclosure

Exhibit 99.1

UNITED STATES BANKRUPTCY COURT
DISTRICT OF DELAWARE

In re MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

MONTHLY OPERATING REPORT
File with Court and submit copy to United States Trustee within 20 days after end of month

Submit copy of report to any official committee appointed in the case.

		Document	Explanation	Affidavit/Supplement
REQUIRED DOCUMENTS	Form No.	Attached	Attached	Attached
Certifications
Schedule of Cash Receipts and Disbursements	MOR-1	X
Bank Reconciliation (or copies of debtor’s bank reconciliations)			see certifications	X
Schedule of Professional Fees Paid	MOR-1b	X
Copies of bank statements			see certifications	X
Cash disbursements journals		X
Statement of Operations	MOR-2	X
Balance Sheet	MOR-3	X
Status of Postpetition Taxes			see certifications	X
Copies of IRS Form 6123 or payment receipt
Copies of tax returns filed during reporting period
Summary of Unpaid Postpetition Debts	MOR-4	X
Listing of aged accounts payable	MOR-4	X
Accounts Receivable Reconciliation and Aging	MOR-5	X
Debtor Questionnaire	MOR-5	X		X

I declare under penalty of perjury (28 U.S.C. Section 1746) that this report and the attached documents are true and correct to the best of my knowledge and belief.

Signature of Debtor	Date
Signature of Joint Debtor	Date
/s/ Brad ColeSignature of Authorized Individual*	December 20, 2010Date
Brad ColePrinted Name of Authorized Individual	SVP, General CounselTitle of Authorized Individual

* Authorized individual must be an officer, director or shareholder if debtor is a corporation; a partner if debtor is a partnership; a manager or member if debtor is a limited liability company.

UNITED STATES BANKRUPTCY COURT
DISTRICT OF DELAWARE

In re MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

CERTIFICATIONS

A. Bank Reconciliation Certification

The undersigned verifies that, to my knowledge, all of the Debtors’ November 30, 2010 bank balances have been reconciled in an accurate and timely manner.

Bank Name	Account		Book Balance
Capital One Bank		****8899	$	2,969,110.21
Capital One Bank		****8910	$	10,000.00
Capital One Bank		****9471	$	13,518,751.50

B. Post-petition Taxes Certification

The undersigned verifies that, to my knowledge, all post-petition tax obligations, including but not limited to payroll, real property, income, franchise and other taxes have been paid to the proper taxing authority when due.

/s/ David CarlsonSignature of Authorized Individual	December 20, 2010Date
David CarlsonPrinted Name of Authorized Individual	VP, Finance and TreasurerTitle of Authorized Individual

In re: MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

MOR 1

	Current Month						Cumulative Filing to Date
	Actual			Forecast			Actual			Forecast
Beginning Date	1-Nov-10			1-Nov-10			3-May-10			3-May-10
Ending Date	30-Nov-10			30-Nov-10			30-Nov-10			30-Nov-10
Cash — Beginning Balance	$	17,238,045		$	17,393,522		$	5,257,718		$	5,269,539
Receipts
Lockbox		—			—			645,880			299,859
Misc Deposits		154,965			—			17,675,086			18,688,404
Total Receipts	$	154,965		$	—		$	18,320,966		$	18,988,263
Operating Disbursements
Gleacher		—			—			(712,514	)		—
Dr Directory		—			—			(77,948	)		(127,774	)
Legal & Deal fees		(107,772	)		(110,847	)		(1,087,202	)		(881,358	)
KCC LLC		(6,836	)		(15,000	)		(65,501	)		(130,513	)
Creditors Committee Counsel & FA		(8,826	)		(150,000	)		(273,538	)		(545,066	)
Equity Committee Counsel		(54,417	)		(54,417	)		(94,294	)		(244,294	)
Other Professional Fees		—			(168,283	)		—			(347,480	)
Payroll		(34,610	)		(41,000	)		(1,177,341	)		(1,450,830	)
Benefits		(46,922	)		(50,000	)		(263,052	)		(206,567	)
Severance		—			—			—			—
Invoices in A/P Aging		—			(6,349	)		(1,218,559	)		(1,159,397	)
Misc (TX rent, Insurance, ICS)		(592,263	)		(26,040	)		(1,025,834	)		(350,476	)
Other		(43,503	)		(32,000	)		(1,089,789	)		(1,240,458	)
voided checks		—			—			4,749			—
Total Operating Disbursements	$	(895,148	)	$	(653,936	)	$	(7,080,822	)	$	(6,684,212	)
Net Operating Cash Flow	$	(740,183	)	$	(653,936	)	$	11,240,143		$	12,304,051
Non-Operating Disbursements
Capex
Professional Fees
Total Non-Operating Disbursements	$	—		$	—		$	—		$	—
Net Operating Cash Flow Before Financing	$	(740,183	)	$	(653,936	)	$	11,240,143		$	12,304,051
Financing Activities
Interest Payments
Financing Activities	$	—		$	—		$	—		$	—
Cash Flow	$	(740,183	)	$	(653,936	)	$	11,240,143		$	12,304,051
Ending Cash Balance (per books)	$	16,497,862		$	16,739,586		$	16,497,862		$	17,573,590

DISBURSEMENTS FOR CALCULATING U.S. TRUSTEE QUARTERLY FEES: (FROM CURRENT MONTH ACTUAL COLUMN)
TOTAL DISBURSEMENTS	$	(895,148	)
LESS: TRANSFERS TO DEBTOR IN POSSESSION ACCOUNTS	$	0
PLUS: ESTATE DISBURSEMENTS MADE BY OUTSIDE SOURCES (i.e. from escrow accounts)	$	0
TOTAL DISBURSEMENTS FOR CALCULATING U.S. TRUSTEE QUARTERLY FEES	$	(895,148	)

In re: MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

Disbursements Journal

Checks cut during period

GL Posting		Checkbook
Date	Source Document	Amount		CM Trx Number	Voided	Paid ToRcvd From
11/24/2010	PMCHK	$	1,527.69	5310	No	A1 DOCUMENT SOLUTIONS, LLC
11/17/2010	PMCHK	$	2,995.85	5298	No	ADP
11/17/2010	PMCHK	$	79.60	5289	No	ADP Commercial Leasing
11/4/2010	PMCHK	$	80,651.95	5286	No	Alston & Bird LLP
11/17/2010	PMCHK	$	1,560.35	5297	No	Amber Tomlinson
11/17/2010	PMCHK	$	1,050.00	5288	No	American Stock Transfer & Trust Co
11/17/2010	PMCHK	$	144.15	5290	No	AT&T Mobility
11/4/2010	PMCHK	$	1,043.44	5276	No	ATT
11/4/2010	PMCHK	$	651.93	5277	No	Avaya, inc.
11/17/2010	PMCHK	$	8,825.95	5291	No	Bayard, P.A.
11/17/2010	PMCHK	$	243.60	5303	No	Brad Cole
11/22/2010	PMCHK	$	1,892.12	5309	No	Brad Cole
11/4/2010	PMCHK	$	1,326.01	5278	No	David Carlson
11/17/2010	PMCHK	$	869.37	5292	No	David Carlson
11/4/2010	PMCHK	$	8,539.99	5279	No	Delaware Secretary of State
11/17/2010	PMCHK	$	3,755.69	5308	No	Delaware Secretary of State
11/4/2010	PMCHK	$	675.00	5283	No	Dr. Donald J. Treacy
11/4/2010	PMCHK	$	60.00	5280	No	Excel Micro
11/17/2010	PMCHK	$	28.00	5293	No	Excel Micro
11/4/2010	PMCHK	$	2,372.50	5281	No	Herman Technology Consultants-LLC
11/17/2010	PMCHK	$	9,205.84	5294	No	Herman Technology Consultants-LLC
11/24/2010	PMCHK	$	2,600.00	5313	No	Herman Technology Consultants-LLC
11/17/2010	PMCHK	$	38.00	5295	No	Iron Mountain
11/17/2010	PMCHK	$	6,835.84	5299	No	Kurtzman Carson Consultants
11/17/2010	PMCHK	$	6,117.11	5307	No	Maguire Partners-Solana Limited Partnership
11/4/2010	PMCHK	$	28,200.40	5285	No	MORRIS JAMES LLP
11/17/2010	PMCHK	$	26,216.33	5302	No	MORRIS JAMES LLP
11/4/2010	PMCHK	$	200.00	5282	No	PayFlex Systems USA, Inc.
11/17/2010	PMCHK	$	979.00	5304	No	Pure Compliance
11/17/2010	PMCHK	$	50.00	5296	No	Shred-it USA, DBA Shred-it Dallas
11/17/2010	PMCHK	$	46,456.82	5300	No	United Healthcare Insurance Co.
11/17/2010	PMCHK	$	464.94	5301	No	UNUM
11/24/2010	PMCHK	$	334.30	5311	No	Verizon Wireless
11/4/2010	PMCHK	$	20.00	5284	No	WorldWide express
11/17/2010	PMCHK	$	125.69	5305	No	WorldWide express
11/24/2010	PMCHK	$	427.67	5312	No	WorldWide express
11/4/2010	PMCHK	$	10,376.95	5287	No	Young Conaway Stargatt & Taylor LLP
11/17/2010	PMCHK	$	16,743.11	5306	No	Young Conaway Stargatt & Taylor LLP
		$	273,685.19	Checks Cut

Debits to bank other than checks

Transaction					Customer
Date	Description	Amount		Bank Ref#	Ref. #	Payee / Description
11/5/2010	Payroll Fees	$	326.11	WDL000001225	CMTRX	ADP
11/10/2010	Payroll	$	14,435.78	WDL000001227	CMTRX	ADP
11/12/2010	Payroll Taxes	$	5,738.80	WDL000001228	CMTRX	ADP
11/19/2010	Payroll Fees	$	310.96	WDL000001234	CMTRX	ADP
11/26/2010	Payroll	$	14,435.77	OEX000001235	CMTRX	ADP
11/26/2010	Payroll Fees	$	70.05	OEX000001236	CMTRX	ADP
11/24/2010	D&O Insurance	$	586,145.00	035279	CMTRX	William Gallagher Associates
		$	621,462.47	Debits to Bank other than Checks
Voided Checks from Prior Periods		$	0.00
		$	895,147.66	Total disbursements

GL Posting		Checkbook
Date	Source Document	Amount		CM Trx Number	Voided	Paid ToRcvd From
Checks cleared by bank:
11/1/2010	DEBIT MEMO - CapOne	$	1,987.65			CONTROL DISBURSEMENT/CLEARED CHECKS
11/2/2010	DEBIT MEMO - CapOne	$	120,651.40			CONTROL DISBURSEMENT/CLEARED CHECKS
11/3/2010	DEBIT MEMO - CapOne	$	94,536.55			CONTROL DISBURSEMENT/CLEARED CHECKS
11/4/2010	DEBIT MEMO - CapOne	$	19,349.45			CONTROL DISBURSEMENT/CLEARED CHECKS
11/5/2010	DEBIT MEMO - CapOne	$	52,137.95			CONTROL DISBURSEMENT/CLEARED CHECKS
11/9/2010	DEBIT MEMO - CapOne	$	114,241.10			CONTROL DISBURSEMENT/CLEARED CHECKS
11/10/2010	DEBIT MEMO - CapOne	$	29,918.84			CONTROL DISBURSEMENT/CLEARED CHECKS
11/12/2010	DEBIT MEMO - CapOne	$	1,326.01			CONTROL DISBURSEMENT/CLEARED CHECKS
11/15/2010	DEBIT MEMO - CapOne	$	20.00			CONTROL DISBURSEMENT/CLEARED CHECKS
11/16/2010	DEBIT MEMO - CapOne	$	10,376.95			CONTROL DISBURSEMENT/CLEARED CHECKS
11/19/2010	DEBIT MEMO - CapOne	$	2,372.50			CONTROL DISBURSEMENT/CLEARED CHECKS
11/22/2010	DEBIT MEMO - CapOne	$	979.00			CONTROL DISBURSEMENT/CLEARED CHECKS
11/23/2010	DEBIT MEMO - CapOne	$	28.00			CONTROL DISBURSEMENT/CLEARED CHECKS
11/24/2010	DEBIT MEMO - CapOne	$	103,329.13			CONTROL DISBURSEMENT/CLEARED CHECKS
11/26/2010	DEBIT MEMO - CapOne	$	19,084.12			CONTROL DISBURSEMENT/CLEARED CHECKS
11/30/2010	DEBIT MEMO - CapOne	$	8,217.68			CONTROL DISBURSEMENT/CLEARED CHECKS
		$	578,556.33

In re: MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

SCHEDULE OF PROFESSIONAL FEES AND EXPENSES PAID
This schedule is to include all retained professional payments from case inception to current month

		Invoice		Invoice
		Amount -		Amount -		Fees		Expenses		Objection	Check		Amount Paid				Year-To-Date
Payee	Period Covered	Fees		Expenses		Approved		Approved		Deadline	Number	Date	Fees		Expenses		Fees		Expenses
Alston & Bird LLP	4/30 - 5/31/10	$	255,194.00	$	0.00	$	255,194.00	$	0.00	7/7/2010	5082	7/21/2010	$	204,155.20	$	0.00	$	204,155.20	$	0.00
Alston & Bird LLP	4/30 - 5/31/10	$	0.00	$	5,825.95	$	0.00	$	5,825.95	7/7/2010	5085	7/22/2010	$	0.00	$	5,825.95	$	0.00	$	5,825.95
Alston & Bird LLP	6/1 - 6/30/10	$	129,621.50	$	7,762.21	$	129,621.50	$	7,762.21	8/5/2010	5107	8/12/2010	$	103,697.20	$	7,762.21	$	103,697.20	$	7,762.21
Alston & Bird LLP	7/1 - 7/31/10	$	100,767.00	$	1,689.29	$	100,767.00	$	1,689.29	9/3/2010	5170	9/8/2010	$	80,613.60	$	1,689.29	$	80,613.60	$	1,689.29
Alston & Bird LLP	8/1 - 8/31/10	$	99,230.00	$	2,430.75	$	99,230.00	$	2,430.75	10/4/2010	5243	10/7/2010	$	79,384.00	$	2,430.75	$	79,384.00	$	2,430.75
Alston & Bird LLP	4/30 - 7/31/10*									11/1/2010	5263	10/27/2010	$	97,116.50	$	0.00	$	97,116.50	$	0.00
Alston & Bird LLP	9/1 - 9/31/10	$	104,208.00	$	285.55	$	104,208.00	$	285.55	11/2/2010	5286	11/4/2010	$	80,366.40	$	285.55	$	80,366.40	$	285.55
Alston & Bird LLP	10/1 - 10/31/10	$	126,101.00	$	2,337.07	$	126,101.00	$	2,337.07	12/6/2010	5333	12/9/2010	$	100,880.80	$	2,337.07	$	100,880.80	$	2,337.07
Alston & Bird LLP subtotal																	$	746,213.70	$	20,330.82
Bayard, P.A.	5/11 - 5/31/10	$	35,663.00	$	212.04	$	35,663.00	$	212.04	7/19/2010	5086	7/22/2010	$	28,530.40	$	212.04	$	28,530.40	$	212.04
Bayard, P.A.	6/1 - 6/30/10	$	29,506.00	$	393.24	$	28,306.00	$	393.24	8/10/2010	5142	8/17/2010	$	22,644.80	$	393.24	$	22,644.80	$	393.24
Bayard, P.A.	7/1 - 7/31/10	$	24,458.00	$	623.21	$	24,458.00	$	623.21	9/7/2010	5212	9/14/2010	$	19,566.40	$	623.21	$	19,566.40	$	623.21
Bayard, P.A.	8/1 - 8/31/10	$	14,119.00	$	366.86	$	14,119.00	$	366.86	10/7/2010	5257	10/20/2010	$	11,295.20	$	366.86	$	11,295.20	$	366.86
Bayard, P.A.	4/30 - 7/31/10*									10/19/2010	5275	10/27/2010	$	17,685.40	$	0.00	$	17,685.40	$	0.00
Bayard, P.A.	9/1 - 9/31/10	$	10,673.50	$	287.15	$	10,673.50	$	287.15	11/2/2010	5291	11/17/2010	$	8,538.80	$	287.15	$	8,538.80	$	287.15
Bayard, P.A.	10/1 - 10/31/10	$	6,568.50	$	191.38					12/14/2010							$	0.00	$	0.00
Bayard, P.A. subtotal																	$	108,261.00	$	1,882.50
Carella, Byrne, Bain	annuity services	$	450.00	$	6,993.00	$	450.00	$	6,993.00	N/A	5044	7/2/2010	$	450.00	$	6,993.00	$	450.00	$	6,993.00
Carella, Byrne, Bain	patent maintenance	$	50.00	$	516.00	$	50.00	$	516.00	N/A	2588	6/21/2010	$	50.00	$	516.00	$	50.00	$	516.00
Carella, Byrne, Bain subtotal																	$	500.00	$	7,509.00
Dickstein Shapiro LLP	5/11 - 5/31/10	$	134,068.50	$	4,147.20	$	134,068.50	$	4,147.20	7/19/2010	5087	7/22/2010	$	107,254.80	$	4,147.20	$	107,254.80	$	4,147.20
Dickstein Shapiro LLP	6/1 - 6/30/10	$	63,546.50	$	3,309.16	$	63,546.50	$	3,309.16	8/10/2010	5131	8/17/2010	$	50,837.50	$	3,309.16	$	50,837.50	$	3,309.16
Dickstein Shapiro LLP	7/1 - 7/31/10	$	63,076.25	$	2,223.29	$	63,076.25	$	2,223.29	9/3/2010	5191	9/8/2010	$	50,461.00	$	2,223.29	$	50,461.00	$	2,223.29
Dickstein Shapiro LLP	8/1 - 8/31/10	$	28,955.00	$	973.23	$	28,955.00	$	973.23	10/5/2010	5248	10/13/2010	$	23,164.00	$	973.23	$	23,164.00	$	973.23
Dickstein Shapiro LLP	4/30 - 7/31/10*									10/19/2010	5264	10/27/2010	$	52,137.95	$	0.00	$	52,137.95	$	0.00
Dickstein Shapiro LLP	9/1 - 9/31/10	$	43,782.00	$	3,606.17	$	43,782.00	$	3,606.17	11/19/2010	5317	12/2/2010	$	35,025.60	$	3,606.17	$	35,025.60	$	3,606.17
Dickstein Shapiro LLP	10/1 - 10/31/10	$	23,127.00	$	23.79	$	23,127.00	$	23.79	11/30/2010	5338	12/16/2010	$	18,501.60	$	23.79	$	18,501.60	$	23.79
Dickstein Shapiro LLP subtotal																	$	337,382.45	$	14,282.84
Gleacher & Company	4/30 - 7/31/10	$	660,000.00	$	52,514.48	$	660,000.00	$	52,514.48	9/7/2010	Wire	9/17/2010	$	528,000.00	$	52,514.48	$	528,000.00	$	52,514.48
Gleacher & Company	4/30 - 7/31/10*									9/30/2010	5240	10/20/2010	$	132,000.00	$	0.00	$	132,000.00	$	0.00
Gleacher & Company subtotal																	$	660,000.00	$	52,514.48
Invotex, Inc.	5/26 - 6/30/10	$	71,248.50	$	374.04	$	71,248.50	$	374.04	8/12/2010	5149	8/27/2010	$	56,998.80	$	374.04	$	56,998.80	$	374.04
Invotex, Inc.	7/1 - 7/30/10	$	14,514.25	$	79.24	$	14,514.25	$	79.24	9/7/2010	5208	9/14/2010	$	11,611.40	$	79.24	$	11,611.40	$	79.24
Invotex, Inc.	4/30 - 7/31/10*									10/19/2010	5267	10/27/2010	$	17,152.55	$	0.00	$	17,152.55	$	0.00
Invotex, Inc. subtotal																	$	85,762.75	$	453.28
Kurtzman Carson Consultants	4/30/2010	$	2,232.00	$	78.20	$	2,232.00	$	78.20	N/A	5029	7/1/2010	$	2,232.00	$	78.20	$	2,232.00	$	78.20
Kurtzman Carson Consultants	NYTIMES (July)	$	0.00	$	3,680.00	$	0.00	$	3,680.00	N/A	wire	7/9/2010		0		3,680.00	$	0.00	$	3,680.00
Kurtzman Carson Consultants	5/1 - 5/31/10	$	44,420.50	$	13,040.83	$	44,420.50	$	13,040.83	N/A	5080	7/21/2010	$	44,420.50	$	13,040.83	$	44,420.50	$	13,040.83
Kurtzman Carson Consultants	6/1 - 6/30/10	$	25,815.50	$	2,752.13	$	25,815.50	$	2,752.13	N/A	5096	7/27/2010	$	25,815.50	$	2,752.13	$	25,815.50	$	2,752.13
Kurtzman Carson Consultants	7/1 - 7/31/10	$	20,333.00	$	5,180.49	$	20,333.00	$	5,180.49	N/A	5150	8/27/2010	$	20,333.00	$	5,180.49	$	20,333.00	$	5,180.49
Kurtzman Carson Consultants	8/1 - 8/31/10	$	15,765.50	$	4,964.56	$	15,765.50	$	4,964.56	N/A	5221	9/23/2010	$	15,765.50	$	4,964.56	$	15,765.50	$	4,964.56
Kurtzman Carson Consultants	9/1 - 9/31/10	$	9,943.00	$	2,478.30	$	9,943.00	$	2,478.30	N/A	5268	10/27/2010	$	9,943.00	$	2,478.30	$	9,943.00	$	2,478.30
Kurtzman Carson Consultants	10/1 - 10/31/10	$	5,551.50	$	1,284.34	$	5,551.50	$	1,284.34	N/A	5299	11/17/2010	$	5,551.50	$	1,284.34	$	5,551.50	$	1,284.34
Kurtzman Carson Consultants subtotal																	$	124,061.00	$	33,458.85
Morris James LLP	7/1 - 7/31/10	$	49,525.00	$	256.57	$	49,525.00	$	256.57	9/20/2010	5227	9/23/2010	$	39,620.00	$	256.57	$	39,620.00	$	256.57
Morris James LLP	8/1 - 8/31/10	$	34,667.00	$	466.80	$	34,667.00	$	466.80	10/27/2010	5285	11/4/2010	$	27,733.60	$	466.80	$	27,733.60	$	466.80
Morris James LLP	9/1 - 9/31/10	$	31,957.50	$	650.33	$	31,957.50	$	650.33	11/8/2010	5302	11/17/2010	$	25,566.00	$	650.33	$	25,566.00	$	650.33
Morris James LLP	10/1 - 10/31/10	$	36,967.00	$	697.22					12/23/2010							$	0.00	$	0.00
Morris James LLP subtotal																	$	92,919.60	$	1,373.70
Young Conaway Stargatt & Taylor LLP	4/30 - 5/31/10	$	41,889.00	$	0.00	$	41,889.00	$	0.00	7/16/2010	5083	7/21/2010	$	33,511.20			$	33,511.20
Young Conaway Stargatt & Taylor LLP	4/30 - 5/31/10	$	0.00	$	1,099.45	$	0.00	$	1,099.45	7/16/2010	5088	7/22/2010			$	1,099.45			$	1,099.45
Young Conaway Stargatt & Taylor LLP	6/1 - 6/30/10	$	25,033.50	$	636.75	$	25,033.50	$	636.75	8/9/2010	5129	8/12/2010	$	20,026.80	$	636.75	$	20,026.80	$	636.75
Young Conaway Stargatt & Taylor LLP	7/1 - 7/31/10	$	19,341.00	$	1,717.81	$	19,341.00	$	1,717.81	8/31/2010	5190	9/8/2010	$	15,472.80	$	1,717.81	$	15,472.80	$	1,717.81
Young Conaway Stargatt & Taylor LLP	4/30 - 7/31/10*									10/19/2010	5274	10/27/2010	$	17,152.70	$	0.00	$	17,152.70	$	0.00
Young Conaway Stargatt & Taylor LLP	8/1 - 8/31/10	$	12,374.00	$	477.75	$	12,374.00	$	477.75	11/3/2010	5287	11/4/2010	$	9,899.20	$	477.75	$	9,899.20	$	477.75
Young Conaway Stargatt & Taylor LLP	9/1 - 9/31/10	$	19,556.50	$	1,097.91	$	19,556.50	$	1,097.91	11/12/2010	5306	11/17/2010	$	15,645.20	$	1,097.91	$	15,645.20	$	1,097.91
Young Conaway Stargatt & Taylor LLP	10/1 - 10/31/10	$	18,569.50	$	420.28					12/22/2010							$	0.00	$	0.00
Young Conaway Stargatt & Taylor LLP subtotal																	$	111,707.90	$	5,029.67
Total																	$	2,266,808.40	$	136,835.14

* Denotes Payment on remaining amounts due through quarterly filings.

In re: MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

	November			Cumulative
	2010			Filing to Date
Gross Sales	$	—		$	438,100
Sales Reserves and Allowances		—			337,779
Net Revenue	$	—		$	775,879
Cost of Goods Sold	$	—		$	860,166
Salaries, Bonus & Temp Labor		44,522			3,400,658
Benefits, Payroll Taxes, Recruiting & Relocation		17,122			129,683
Subtotal: Salaries & Benefits	$	61,644		$	3,530,340
Stock-Based Compensation		—			408,171
Marketing & Advertising		—			4,011
Travel & Entertainment		3,161			57,035
Facilities and Equipment Related		394,173			683,435
Insurance		66,558			527,354
Distribution Expense		—			359,749
Office & General Lab Supplies		1,712			13,539
Consulting & Legal Fees		177,947			3,429,961
Patents & Licensing		—			214,613
Audit, IR & Financial Fees		7,864			(42,035	)
Non-Income Taxes		3,390			31,996
Depreciation and Amortization		—			974,542
Director and SAB Fees		—			64,771
Subtotal: FTE Expenses	$	716,450		$	10,257,482
Marketing Costs		—			169,576
Direct Project Costs		—			53,114
Total Expenses	$	716,450		$	11,340,338
Income (Loss) from Operations	$	(716,450	)	$	(10,564,458	)
Interest Income		7,257			22,489
Other income (expense)		128,292			162,411
Net Income (Loss) Before Taxes	$	(580,900	)	$	(10,379,558	)
Net Income (Loss)	$	(580,900	)	$	(10,379,558	)

In re: MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

	Current			Petition
	Month			Date
Cash & Cash Equivalents	$	16,497,862		$	5,257,718
Accounts Receivable, net		5,233			(490,487	)
Inventory		—			2,213,158
Prepaid and Other Current Assets		1,094,744			3,397,106
Property and Equipment		—			14,341,773
Accumulated Depreciation		—			(12,460,925	)
Property and Equipment, net		—			1,880,848
Deposits and Other Assets		167,705			680,580
Intangible Assets		—			11,877,529
Accum. Amort — Intangibles		—			(2,643,218	)
Intangible Assets, net		—			9,234,311
Total Assets	$	17,765,543		$	22,173,234
Accounts Payable — post-petition		(277,976	)		—
Accrued Payable to Lilly		—			—
Accrued Professional Fees		(639,000	)		—
Accounts Payable and Accrued Expenses — Post-Petition		(922,195	)		—
Accounts Payable — pre-petion		(909,551	)		(1,214,588	)
Accrued Severance		(2,432,458	)		(281,258	)
Accrued Payable to Lilly		—			(5,252	)
Accrued Professional Fees		(30,000	)		(199,917	)
Accrued R&D Costs		—			(136,067	)
Accrued Keflex Copay Assistance		—			(9,276	)
Accrued Moxatag Copay Assistance		—			(3,705,035	)
Accrued Medicaid Rebates Payable		(1,402	)		(563,001	)
Accrued Returns		—			(1,945,797	)
Other Accrued Expenses		—			(292,773	)
Wages Payable		(232,412	)		(306,521	)
Employee Benefits Pay-401k		—			(33,339	)
Employee Benefits — Flex Spending		—			(3,899	)
Other Current Liabilities		(2,261,875	)		(4,810,772	)
Accounts Payable and Accrued Expenses — Pre-Petition		(5,867,698	)		(13,507,496	)
Deferred Contract Revenue — non-current (pre-petition)		(3,500,000	)		(11,625,000	)
Deferred Lease Expense		—			(18,340	)
Total Liabilities	$	(10,289,892	)	$	(25,150,836	)
Common Stock		(865,119	)		(865,119	)
Additional Paid in Capital		(322,373,995	)		(312,281,358	)
Retained Earnings		288,500,568			299,240,744
YTD P&L		27,262,895			16,883,336
Accumulated Deficit		315,763,463			316,124,080
Stockholders’ Equity	$	(7,475,651	)	$	2,977,602
Liabilities & Stockholders’ Equity	$	(17,765,543	)	$	(22,173,234	)

In re: MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

Other Post-petition liabilities
Professional bankruptcy fees estimates — equity committee counsel	$	200,000
Professional legal fees		169,000
Professional bankruptcy fees estimates — corporate and local counsel		150,000
Professional bankruptcy fees estimates — creditors’ committee cousel & FA		100,000
Professional bankruptcy fees — KCC estimate		20,000
Total of Accrued Professional Fees (acct 21210)	$	639,000

In re: MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

SUMMARY OF UNPAID POSTPETITION DEBTS

		Voucher		Document		Current Trx			Document
Vendor ID	Vendor Name	Number		Date		Amount		Document Number	Type	Paid Date
ALS002	Alston & Bird LLP		038621		8/31/2010	$	19,846.00	AUG 20%	Invoice
ALS002	Alston & Bird LLP		038680		9/30/2010	$	20,841.60	SEP 20%	Invoice
ALS002	Alston & Bird LLP		038754		10/31/2010	$	25,220.20	OCT 20%	Invoice
ALS002	Alston & Bird LLP		038755		10/31/2010	$	100,880.80	OCT 80%	Invoice		12/09/10
ALS002	Alston & Bird LLP		038756		10/31/2010	$	2,337.07	OCT EXP	Invoice		12/09/10
BAY002	Bayard, P.A.		038641		8/31/2010	$	2,823.80	AUG 20%	Invoice
BAY002	Bayard, P.A.		038685		9/30/2010	$	2,134.70	SEP 20%	Invoice
BAY002	Bayard, P.A.		038766		10/31/2010	$	1,313.70	OCT 20%	Invoice
BAY002	Bayard, P.A.		038767		10/31/2010	$	5,254.80	OCT 80%	Invoice
BAY002	Bayard, P.A.		038768		10/31/2010	$	191.38	OCT EXP	Invoice
CSC003	Corporation Service Company		038770		9/22/2010	$	3,901.50	73162446	Invoice		12/02/10
CAR012	David Carlson		038769		11/30/2010	$	115.64	11302010	Invoice		12/02/10
DIC002	Dickstein Shapiro LLP		038634		8/31/2010	$	5,791.00	AUG 20%	Invoice
DIC002	Dickstein Shapiro LLP		038746		9/30/2010	$	8,756.40	SEP 20%	Invoice
DIC002	Dickstein Shapiro LLP		038747		9/30/2010	$	35,025.60	SEP 80%	Invoice		12/02/10
DIC002	Dickstein Shapiro LLP		038748		9/30/2010	$	3,606.17	SEP EXP	Invoice		12/02/10
HER004	Herman Technology Consultants-LLC		038771		11/28/2010	$	1,235.00	014	Invoice		12/02/10
ICS001	Integrated Commercialization Sol.		038730		11/3/2010	$	9,352.93	151-10014205	Invoice		12/02/10
MOR008	MORRIS JAMES LLP		038563		8/30/2010	$	9,905.00	JULY FEES 20%	Invoice
MOR008	MORRIS JAMES LLP		038669		8/31/2010	$	6,933.40	AUG FEES 20%	Invoice
MOR008	MORRIS JAMES LLP		038689		9/30/2010	$	6,391.50	SEP 20%	Invoice
PUR001	Pure Compliance		038772		11/23/2010	$	451.00	C08853	Invoice		12/02/10
WIL002	William Gallagher Associates		038774		11/24/2010	$	3,192.00	140843	Invoice		12/02/10
YOU005	Young Conaway Stargatt & Taylor LLP		038700		8/31/2010	$	2,474.80	AUG 20%	Invoice
						$	277,975.99

In re: MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

SUMMARY OF UNPAID POSTPETITION DEBTS

Attach aged listing of accounts payable.

			Number of Days Past Due
	Current		0-30		31-60		61-90		Over 90		Total
Accounts Payable	$	18,249	$	—	$	—	$	—	$	—	$	18,249
Wages Payable (401k contributions)		—		—		—		—		—		—
Taxes Payable (payroll-related taxes)		—		—		—		—		—		—
Rent/Leases-Building		—		—		—		—		—		—
Rent/Leases-Equipment		—		—		—		—		—		—
Secured Debt/Adequate Protection Payments		—		—		—		—		—		—
Professional Fees*		—		135,198		76,755		47,774				259,727
Amounts Due to Insiders**		—		—		—		—		—		—
Other:		—		—		—		—		—		—
Other:		—		—		—		—		—		—
Total Postpetition Debts	$	18,249	$	135,198	$	76,755	$	47,774	$	—	$	277,976

Explain how and when the Debtor intends to pay any past-due postpetition debts.

*	Professional fees are awaiting court approval or include remaining 20% of fees.
**	“Insider” is defined in 11 U.S.C. Section 101(31).

In re: MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

ACCOUNTS RECEIVABLE RECONCILIATION AND AGING

Accounts Receivable Reconciliation	Amount
Total Accounts Receivable at the beginning of the reporting period	$	5,232.87
+ Amounts billed during the period		—
- Amounts collected during the period		—
- Other adjustments during period		—
Total Accounts Receivable at the end of the reporting period		5,232.87

Accounts Receivable Aging	Amount
0 - 30 days old		—
31 - 60 days old		—
61 - 90 days old		—
91+ days old		5,232.70
Total Accounts Receivable		5,232.70
Amount considered uncollectible (Bad Debt)
Accounts Receivable (Net)	$	5,232.70

DEBTOR QUESTIONNAIRE

Must be completed each month	Yes	No
1. Have any assets been sold or transferred outside the normal course of business this reporting period? If yes, provide an explanation below.	X
2. Have any funds been disbursed from any account other than a debtor in possession account this reporting period? If yes, provide an explanation below.		X
3. Have all postpetition tax returns been timely filed? If no, provide an explanation below.	X
4. Are workers compensation, general liability and other necessary insurance coverages in effect? If no, provide an explanation below.	X
5. Has any bank account been opened during the reporting period? If yes, provide documentation identifying the opened account(s). If an investment account has been opened provide the required documentation pursuant to the Delaware Local Rule 4001-3.		X

Debtor sold certain assets pursuant to the Order Establishing Procedures for the Sale and/or abandonment of Certain Miscellaneous Property [Docket No. 263] dated September 7, 2010 (the “Order”). See the page titled “Sale of Assets “ for a listing of the miscellaneous property sold during the current period pursuant to the Order

In re: MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

SALE OF ASSETS

Date of		Relationship					Purchase
Purchase	Purchaser	to Debtor	Equipment	Model #	Serial #		Amount
11/1/2010	Jay Chenault	None	InFocus IN1100 Projector	IN1100			$	400.00
11/1/2010	Jay Chenault	None	HP 4200 Printer	4200				75.00
11/1/2010	Jay Chenault	None	Onkyo Stereo Receiver					75.00
11/1/2010	Jay Chenault	None	Sanyo Projector	PLC-XU88				150.00
11/1/2010	Jay Chenault	None	2 Reception Chairs					50.00
11/3/2010	Samantha Zirdock	None	Infocus 1100 Projector					385.71
11/3/2010	Thom Gray	None	Samsung 19" Monitor	SyncMaster 920WM				65.00
11/4/2010	Scott Conklin	None	Lenovo X200 Laptop	X200	R90AYDW			375.00
11/4/2010	Scott Conklin	None	Lenovo X200 Laptop	X200	L3ACD7K			375.00
11/4/2010	Scott Conklin	None	Lenovo X200 Laptop	X200	L3ACD7T	��		375.00
11/4/2010	Scott Conklin	None	Lenovo X200 Laptop	X200	L3ACD7B			375.00
11/4/2010	Scott Conklin	None	Fujitsu Laptop					150.00
11/4/2010	Scott Conklin	None	Toshiba Laptop					200.00
11/8/2010	Jay Chenault	None	2 conference tables					300.00
11/8/2010	Jay Chenault	None	15 tan arm conference chairs					250.00
11/8/2010	Jay Chenault	None	4 tan reception chairs					100.00
11/8/2010	Jay Chenault	None	2 hp laser printers and toner					75.00
11/8/2010	Jay Chenault	None	1 laptop					375.00
11/8/2010	Pam McCune	None	8 Wood Bookshelves					480.00
11/8/2010	Pam McCune	None	2 Metal Shelves					100.00
11/8/2010	Pam McCune	None	1 2 Drawer filing cabinet					60.00
11/8/2010	Pam McCune	None	1 Chair					25.00
11/9/2010	Ramesh Akula	None	Lenovo X61 Laptop	x61				300.00
11/9/2010	Ramesh Akula	None	10 Desktops					200.00
11/9/2010	Ramesh Akula	None	Dvd Player					40.00
11/9/2010	Ramesh Akula	None	5 Keyboards					25.00
11/9/2010	Ramesh Akula	None	5 Mice					25.00
11/9/2010	Ramesh Akula	None	HP Printer 3030	3030				50.00
11/9/2010	Ramesh Akula	None	3 Blackberry’s					50.00
11/9/2010	Ramesh Akula	None	1 Hard Drive					30.00
11/9/2010	Ramesh Akula	None	2 Infocus 1100 Projectors	1100				700.00
11/9/2010	Ramesh Akula	None	Infocus Projector					80.00
11/9/2010	Ramesh Akula	None	Toshiba Laptop					100.00
11/9/2010	Ramesh Akula	None	6 Desktops					120.00
11/12/2010	Bob Gonzales	None	2 Infocus 1100 Projectors	1100				700.00
11/14/2010	Eric Maguire	None	15 - 5 Drawer File Cabinets					1,500.00
11/14/2010	Eric Maguire	None	Kitchen Tables & Chairs					400.00

In re: MiddleBrook Pharmaceuticals, Inc.	Case No. 10-11485
Debtor	Reporting Period: November 1 – November 30, 2010

Date of		Relationship				Purchase
Purchase	Purchaser	to Debtor	Equipment	Model #	Serial #	Amount
11/14/2010	Eric Maguire	None	6 Office Desks				450.00
11/14/2010	Eric Maguire	None	3 Book shelves				75.00
11/14/2010	Eric Maguire	None	30 Office Chairs				500.00
11/14/2010	Eric Maguire	None	4 Desk credenzas				175.00
11/14/2010	Eric Maguire	None	2 Desktops				25.00
11/14/2010	Eric Maguire	None	2 Printers				75.00
11/14/2010	Rocky Cherry	None	10 - 5 Drawer Lateral File Cabinets				1,000.00
11/14/2010	Rocky Cherry	None	3 - 2 Drawer Lateral File Cabinets				150.00
11/14/2010	Rocky Cherry	None	1 Leather Chair				50.00
11/14/2010	Rocky Cherry	None	1 Small Conference Table				300.00
11/15/2010	Mike Kaiser	None	Infocus 1100 Projector				350.00
11/15/2010	Sergiu Botez	None	Samsung 19" Monitor				89.15
11/16/2010	Adam Rhodes	None	Infocus 1100 Projector				370.85
11/17/2010	Par Pharmaceuticals	None	MGII Encapsulator	MGII			113,535.60
11/21/2010	Daniel Pohorily	None	Avaya Phone System & Phones				1,500.00
11/28/2010	David Noteware	None	Infocus 1100 Projector				385.71
11/30/2010	Scott Abraham	None	4 JBL Speakers				125.00
					Total:	$	128,292.02